Freestone Capital Holdings, LLC Anavex Life Sciences Corp. Put Options Transaction History
Freestone Capital Holdings, LLC
- $2.67 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AVXL
# of Institutions
160Shares Held
31.6MCall Options Held
910KPut Options Held
1.35M-
State Street Corp Boston, MA7.3MShares$40 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$36.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$24.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$9.39 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC851KShares$4.66 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $427M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...